Literature DB >> 11813243

Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis.

Isaac Veinbergs1, Analisa Everson, Yutaka Sagara, Eliezer Masliah.   

Abstract

The association of the E4 allele of apolipoprotein E (apoE4) as a genetic risk factor for Alzheimer's disease (AD) has been well established. Although recent studies in neuronal cell lines and transgenic mice have shown that apoE4 promotes neurodegeneration, the mechanisms through which apoE4 impairs neuronal viability are not completely understood. In this context, the main objective of the present study was to determine whether the neurotoxic effects of apoE4 are mediated by an alteration in calcium homeostasis. For this purpose, effects of recombinant apoE3 and apoE4 on cell viability and intracellular calcium levels were analyzed in a murine hippocampal cell line (HT22) and in primary rat cortical neurons, in the presence or absence of calcium inhibitors. Under basal conditions, apoE4-treated cells displayed increased levels of cytosolic calcium associated with cell death in a dose-dependent manner. Furthermore, apoE4 treatment potentiated the rise in cytosolic calcium and cell death following the administration of a calcium ionophore. The effects of apoE4 on cell viability and calcium homeostasis were inhibited by calcium chelators or by blocking calcium channels, but not by inhibitors of intracellular calcium reserves. Taken together, these results indicate that the neurotoxic effects of apoE4 are dependent on extracellular calcium influx via calcium channels. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813243     DOI: 10.1002/jnr.10138

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  36 in total

1.  Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers.

Authors:  Joel Kowalewski; Claire Murphy
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

2.  Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.

Authors:  S Kaja; R S Duncan; S Longoria; J D Hilgenberg; A J Payne; N M Desai; R A Parikh; S L Burroughs; E V Gregg; D L Goad; P Koulen
Journal:  Neuroscience       Date:  2010-11-11       Impact factor: 3.590

3.  APOE ε 4 allele and CSF APOE on cognition in HIV-infected subjects.

Authors:  Marilou A Andres; Ute Feger; Avindra Nath; Sody Munsaka; Caroline S Jiang; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-12-24       Impact factor: 4.147

Review 4.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

Review 5.  Role of endolysosomes and inter-organellar signaling in brain disease.

Authors:  Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2019-11-09       Impact factor: 5.996

Review 6.  Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime.

Authors:  MaryKate McBrayer; Ralph A Nixon
Journal:  Biochem Soc Trans       Date:  2013-12       Impact factor: 5.407

7.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

8.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

9.  Diabetes and Alzheimer's disease - is there a connection?

Authors:  Anders A F Sima; Zhen-Guo Li
Journal:  Rev Diabet Stud       Date:  2007-02-10

10.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.